Titre:
  • Introduction of Subcutaneous Infliximab CT-P13 and Vedolizumab in Clinical Practice: A Multi-Stakeholder Position Statement Highlighting the Need for Post-Marketing Studies
Auteur:Fierens, Liselotte; Liefferinckx, Claire; Hoefkens, Eveline; Lobaton, Triana; Dreesen, Erwin; Sabino, Jodelson A.; Ferrante, Marc
Informations sur la publication:Journal of Crohn's and Colitis
Statut de publication:Publié, 2022-01-01
Sujet CREF:Sciences humaines
Langue:Anglais
Identificateurs:urn:issn:1873-9946
info:doi/10.1093/ecco-jcc/jjac009